rss

Author index

December 1997, Volume 52, Issue 12

[Table of contents]
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. al-Shamma, M R

    • Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:12 1056-1059 doi:10.1136/thx.52.12.1056

  2. Ayrey, R B

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

B

  1. Barnes, P J

    • Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:12 1051-1055 doi:10.1136/thx.52.12.1051

  2. Bertrand, J P

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  3. Black, C M

    • Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:12 1051-1055 doi:10.1136/thx.52.12.1051

  4. Britton, J

    • Tobacco: the epidemic we could all avoid. Thorax 1997;52:12 1021-1022 doi:10.1136/thx.52.12.1021

  5. Bronsky, E

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

C

  1. Cailes, J B

    • Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:12 1051-1055 doi:10.1136/thx.52.12.1051

  2. Charlett, A

    • Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997;52:12 1060-1067 doi:10.1136/thx.52.12.1060

  3. Chung, K F

    • Platelet activating factor revisited. Thorax 1997;52:12 1019-1020 doi:10.1136/thx.52.12.1019

  4. Clark, D J

    • Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 1997;52:12 1036-1039 doi:10.1136/thx.52.12.1036

  5. Cook, D G

    • Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997;52:12 1081-1094 doi:10.1136/thx.52.12.1081

D

  1. Darbyshire, J H

    • Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997;52:12 1060-1067 doi:10.1136/thx.52.12.1060

  2. Davies, C W

    • Recurrent post-partum pulmonary eosinophilia. Thorax 1997;52:12 1095-1096 doi:10.1136/thx.52.12.1095

  3. De Vuyst, P

    • Pericardial effusion associated with asbestos exposure. Thorax 1997;52:12 1097-1098 doi:10.1136/thx.52.12.1097

  4. Douglas, N J

    • Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:12 1068-1073 doi:10.1136/thx.52.12.1068

  5. du Bois, R M

    • Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:12 1051-1055 doi:10.1136/thx.52.12.1051

F

  1. Finch, S P

    • Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:12 1068-1073 doi:10.1136/thx.52.12.1068

  2. Fischer, A R

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

  3. Frette, C

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  4. Fukumura, M

    • Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax 1997;52:12 1024-1029 doi:10.1136/thx.52.12.1024

G

  1. Gevenois, P A

    • Pericardial effusion associated with asbestos exposure. Thorax 1997;52:12 1097-1098 doi:10.1136/thx.52.12.1097

  2. Guerreiro, D

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

H

  1. Harman, E

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

  2. Harré, E S

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

  3. Hendeles, L

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

  4. Hill, J B

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

I

  1. Israel, E

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

J

  1. Jacob, M P

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  2. Jungerwirth, S

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

K

  1. Kauffmann, F

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  2. Kharitonov, S A

    • Decreased nitric oxide in the exhaled air of patients with systemic sclerosis with pulmonary hypertension. Thorax 1997;52:12 1051-1055 doi:10.1136/thx.52.12.1051

  3. Koide, K

    • Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax 1997;52:12 1024-1029 doi:10.1136/thx.52.12.1024

  4. Kumar, D

    • Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997;52:12 1060-1067 doi:10.1136/thx.52.12.1060

L

  1. Laurent, P

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  2. Lipworth, B J

    • Effects of airway calibre on lung delivery of nebulised salbutamol. Thorax 1997;52:12 1036-1039 doi:10.1136/thx.52.12.1036

  3. Loper, M

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

M

  1. MacKay, T W

    • Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:12 1068-1073 doi:10.1136/thx.52.12.1068

  2. Mackinlay, C I

    • Recurrent post-partum pulmonary eosinophilia. Thorax 1997;52:12 1095-1096 doi:10.1136/thx.52.12.1095

  3. Martin, I R

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

  4. Massie, R J

    • Montelukast (MK-0476) Thorax 1997;52:12 1099

  5. McCruden, E A

    • Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:12 1056-1059 doi:10.1136/thx.52.12.1056

  6. McLeod, K

    • Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:12 1056-1059 doi:10.1136/thx.52.12.1056

  7. McSharry, C

    • Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:12 1056-1059 doi:10.1136/thx.52.12.1056

  8. Mortimore, I L

    • Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:12 1068-1073 doi:10.1136/thx.52.12.1068

N

  1. Nicholas, S

    • Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997;52:12 1060-1067 doi:10.1136/thx.52.12.1060

P

  1. Pabst, R

    • Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax 1997;52:12 1078-1080 doi:10.1136/thx.52.12.1078

  2. Pham, Q T

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  3. Price, P D

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

R

  1. Reiss, T F

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

  2. Roomes, D

    • Treatment of pleural empyema. Thorax 1997;52:12 1099

  3. Rosenberg, M A

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

  4. Roth, M

    • Effect of a novel 5-lipoxygenase activating protein inhibitor, BAYx 1005, on asthma induced by cold dry air. Thorax 1997;52:12 1074-1077 doi:10.1136/thx.52.12.1074

S

  1. Schroeven, M

    • Pericardial effusion associated with asbestos exposure. Thorax 1997;52:12 1097-1098 doi:10.1136/thx.52.12.1097

  2. Shindo, K

    • Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. Thorax 1997;52:12 1024-1029 doi:10.1136/thx.52.12.1024

  3. Simpson, G

    • Treatment of pleural empyema. Thorax 1997;52:12 1099

  4. Stack, B H

    • Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis. Thorax 1997;52:12 1056-1059 doi:10.1136/thx.52.12.1056

  5. Strachan, D P

    • Health effects of passive smoking. 3. Parental smoking and prevalence of respiratory symptoms and asthma in school age children. Thorax 1997;52:12 1081-1094 doi:10.1136/thx.52.12.1081

T

  1. Tanaka, W K

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

  2. Toop, L J

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

  3. Town, G I

    • Respiratory effects of air pollution in chronic obstructive pulmonary disease: a three month prospective study. Thorax 1997;52:12 1040-1044 doi:10.1136/thx.52.12.1040

  4. Trogrlic, S

    • Pericardial effusion associated with asbestos exposure. Thorax 1997;52:12 1097-1098 doi:10.1136/thx.52.12.1097

  5. Tschernig, T

    • Lymphocyte dynamics: caution in interpreting BAL numbers. Thorax 1997;52:12 1078-1080 doi:10.1136/thx.52.12.1078

W

  1. Wathen, C G

    • Recurrent post-partum pulmonary eosinophilia. Thorax 1997;52:12 1095-1096 doi:10.1136/thx.52.12.1095

  2. Watson, J M

    • Tuberculosis in England and Wales in 1993: results of a national survey. Public Health Laboratory Service/British Thoracic Society/Department of Health Collaborative Group. Thorax 1997;52:12 1060-1067 doi:10.1136/thx.52.12.1060

  3. Wei, S M

    • Relationship of serum elastin peptide level to single breath transfer factor for carbon monoxide in French coal miners. Thorax 1997;52:12 1045-1050 doi:10.1136/thx.52.12.1045

  4. Whittle, A T

    • Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 1997;52:12 1068-1073 doi:10.1136/thx.52.12.1068

Z

  1. Zhang, J

    • Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax 1997;52:12 1030-1035 doi:10.1136/thx.52.12.1030

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.